TRIP13 and colorectal carcinoma: In lysates of SW480p53‐mut,MSS and HT29p53‐mut,MSS CRC cells, there was an apparent interaction between TRIP13 and FGFR4 (Fig. 5E), indicating the involvement of TRIP13 in activation of the EGFR signaling pathway through FGFR4.